Navigation Links
Kendle Announces CEO Succession Plan, Promotes Stephen Cutler, PhD, to President and CEO
Date:2/14/2011

critical period in our history and has been a key architect of our return-to-growth strategy. I have enjoyed working with him and the Board as part of the planned succession process and look forward to working together to ensure a smooth and orderly transition."

"I am thrilled to lead Kendle through the next chapter in its growth," said Dr. Cutler. "As a result of Candace's leadership, we are poised for growth in the fastest-growing segment of outsourced clinical development services. Our focus is on differentiating Kendle through best-in-class delivery and innovative solutions leveraging creative patient access and retention approaches, cost-effective drug development models and emerging market capabilities. I look forward to continuing to work closely with Candace, our senior management team and our associates around the globe to deliver best-in-class clinical development solutions for our customers and exceptional value for our shareholders."

Dr. Cutler joined Kendle in 2009 as Senior Vice President and COO and since that time has provided global leadership for the Company's worldwide Late Stage operations. Prior to Kendle, Dr. Cutler spent 14 years with Quintiles where he served as Senior Vice President, Global Project Management; Senior Vice President, Clinical, Medical and Regulatory; Senior Vice President, Project Management – Europe; and Vice President, Oncology – Europe as well as regional leadership positions in South Africa and Australia.  Prior to joining Quintiles Dr. Cutler held positions with Sandoz (now Novartis) in Australia and Europe. He holds a Doctorate in Philosophy from the University of Sydney in Sydney, Australia, and a Master's of Business Administration from the University of Birmingham in Birmingham, England. Dr. Cutler represents Kendle on the Board of Directors of the Association of Clinical Research Organizations (ACRO).

Assuming the role of Senior Vice President and COO from Dr. Cutler will be Ja
'/>"/>

SOURCE Kendle International Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Kendle to Present at Lazard Capital Markets 7th Annual Healthcare Conference
2. Kendle Announces Details Regarding Third Quarter 2010 Earnings Conference Call and Webcast
3. Kendle Appoints Mark J. Roseman, D.Sc., Senior Vice President and Chief Marketing Officer
4. Kendle Announces Details Regarding Second Quarter 2010 Earnings Conference Call and Webcast
5. Kendle to Present at 2010 Wells Fargo Securities Healthcare Conference
6. Kendle Advances Early Stage Drug Development with ElMindAs Innovative Brain Network Activation Technology
7. Kendle Director of Global Safety and Pharmacovigilance, Drew Kilpatrick, PhD, Named One of Ten Notable People in R&D
8. Kendle Executive to Share Insights at World Pharma Trials Asia 2010
9. Kendle is First Global CRO to Achieve ISO 9001:2008 Certification in China Through Beijing Affiliate
10. Kendle Launches New Global Biostatistics Infrastructure
11. Kendle Receives Approval From Indian Government to Proceed With Development of Operations Center in Special Economic Zone
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2015)... , July 31, 2015 ... decades of experience, the domestic pharmaceutical industry is strong, ... manufacture products to high international standards. One ... known is in sub-Saharan Africa: Morocco has quietly become ... South Africa . Indeed, Moroccan pharma ...
(Date:7/31/2015)... , July 31, 2015  Xencor, Inc. (NASDAQ: ... antibodies for the treatment of autoimmune diseases, asthma and ... Yujiro S. Hata to its board of ... business and corporate development is a tremendous asset to ... and chief executive officer of Xencor. "Xencor faces a ...
(Date:7/30/2015)... International Inc. (NYSE: MTD ) today announced second ... , Sales in local currency increased 3% ... sales decreased 4% as currency reduced sales growth by ... diluted share as reported (EPS) were $2.73, compared with ... , an increase of 9% over the prior-year ...
Breaking Medicine Technology:PharmaBoardroom Releases New Morocco Pharmaceuticals Report 2PharmaBoardroom Releases New Morocco Pharmaceuticals Report 3Xencor Appoints Yujiro S. Hata to Board of Directors 2Xencor Appoints Yujiro S. Hata to Board of Directors 3Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 2Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 3Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 4Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 5Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 6Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 7Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 8Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 9Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 10Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 11Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 12Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 13Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 14
... , , ... Group (MRG), the global authority on medical technology market intelligence, ... enteral feeding devices will be a key driver of the ... MRG,s new US and European Markets for Enteral Feeding ...
... , FORT COLLINS, Colo., Dec. 14 ... 250 mg (chenodiol tablets). On October 22, 2009, ... an important therapy for patients suffering from gallstones in ... disease or advanced age. , Chenodal prescriptions have started ...
Cached Medicine Technology:Enteral Feeding Device Market To Generate More Than $700 Million in the US & Europe by 2014 2Enteral Feeding Device Market To Generate More Than $700 Million in the US & Europe by 2014 3Manchester Announces Availability of Chenodal(TM) 2
(Date:8/1/2015)... ... , ... “ reTXT ” was featured on NewsWatch as part of its ... market for iOS, Android, and Windows. Joe Toohey, the host of AppWatch and technology ... and delete any message including ones already sent. , While text messaging has more ...
(Date:7/31/2015)... New York (PRWEB) , ... July 31, 2015 , ... ... strut their stuff, Super-Sod debuted their new type of sod called Leisure Time(TM) ... trademark application in process. , To commemorate introduction of this new type of sod, ...
(Date:7/31/2015)... ... ... Precision Aesthetics is New York’s only Thermage skin tightening pinnacle and black ... Exilis non-surgical fat reduction in New York. Due to its unparalleled level of ... Many patients travel to New York to get their non-surgical skin tightening and ...
(Date:7/31/2015)... ... ... Sculpted Contours Luxury Medical Aesthetics announces the arrival of the newest applicator for ... applicator in the United States as an upgrade to the CoolSmooth applicator cleared by ... required a 2 hour treatment time. The new CoolSmooth Pro reduces the treatment ...
(Date:7/31/2015)... ... July 31, 2015 , ... Coco Libre announced today that their ... VIPs at the 2015 Vans US Open of Surfing, July 25 through August 2 ... “no added sugar” on the market, is a natural choice given the Open’s commitment ...
Breaking Medicine News(10 mins):Health News:Correct Auto-Correct and Clarify the Unclear with reTXT Messaging App 2Health News:Super-Sod Introduces Leisure Time(TM) Zoysia Grass with an Adirondack Chair Promotion 2Health News:Cooler Coolsculpting in Atlanta: Treatments Now Twice As Fast 2Health News:Cooler Coolsculpting in Atlanta: Treatments Now Twice As Fast 3Health News:Coco Libre Brings Eco-conscious Hydration to Vans US Open of Surfing 2
... has been a mixed response from private professional colleges ... for admission into medical and engineering colleges // . ... admission should be based on higher secondary marks alone. ... private colleges have the right to decide upon admission ...
... enough shut-eye? You're not alone. ,Statistics Canada says more than ... 6-1/2 hours of sleep a night compared with 7-1/2 hours ... per cent of the insomniacs averaged less than five hours ... of Canadians -- 13 per cent -- that have insomnia, ...
... doctors say could change the way we treat breast cancer. The ... help doctors identify breast disease // up to eight years earlier ... ,Breast pap patient Amy Rhoades is taking a screening test that ... years in advance. ,Amy says this Pap test for ...
... a medical tourism destination was the highlight of presentations ... ,India's Minister for Tourism Renuka Chowdhury, who // ... event, said: "Not only is India known for its ... best. The Indians know how to do the best"., ...
... anxiety and improve health status by befriending dogs, according to ... the University of California Los Angeles (UCLA) and others studied ... an estimated five million Americans, reports the online edition of ... breeds, were screened for behaviour and disease before participating in ...
... under the care of an allergist report fewer asthma ... to patients receiving care from primary care physicians. //, ... approximately 20 million Americans, and is responsible for nearly ... 2 million asthma-related visits to the emergency department each ...
Cached Medicine News:Health News:Mixed Opinion Regarding Common Medical And Engineering Entrance Test 2Health News:Asthma Patients Under The Care Of An Allergist Report Less Severe Symptoms 2
0.5 mm angled tip. Round knurled handle with dull finish. Tip angle: 150 degrees....
Angled for easy insertion into side port incision for manipulation of nucleus. Flat, paddle like tip for placement in groove to crack the nucleus for emulsification....
Angled shaft with 0.2 mm hourglass shape tip. Round knurled handle. Manufactured in titanium....
Ideal for nucleus manipulation during phacoemulsification. Also used for manipulating and rotating IOLs within the anterior chamber. Round knurled handle...
Medicine Products: